AAAAAA
Results: 1-25/29
Authors:
Tang, MT
Griffin, JH
Citation: Mt. Tang et Jh. Griffin, A reduced-order model of mistuning using a subset of nominal system modes, J ENG GAS T, 123(4), 2001, pp. 893-900
Authors:
Petaja, J
Pesonen, E
Fernandez, JA
Griffin, JH
Repo, H
Jansson, SE
Vento, AE
Ramo, OJ
Citation: J. Petaja et al., Activated protein C and inflammation in human myocardium after heart surgery, AM J HEMAT, 67(3), 2001, pp. 210-212
Authors:
Griffin, JH
Fernandez, JA
Deguchi, H
Citation: Jh. Griffin et al., Plasma lipoproteins, hemostasis and thrombosis, THROMB HAEM, 86(1), 2001, pp. 386-394
Authors:
Rintelen, C
Yegneswaran, S
Griffin, JH
Citation: C. Rintelen et al., Anticoagulant dysfunction of human Arg352Trp-activated protein C caused bydefective factor Va inactivation, THROMB HAEM, 85(2), 2001, pp. 274-279
Authors:
Buckner, FS
Griffin, JH
Wilson, AJ
Van Voorhis, WC
Citation: Fs. Buckner et al., Potent anti-Trypanosoma cruzi activities of oxidosqualene cyclase inhibitors, ANTIM AG CH, 45(4), 2001, pp. 1210-1215
Authors:
Shibata, M
Kumar, SR
Amar, A
Fernandez, JA
Hofman, F
Griffin, JH
Zlokovic, BV
Citation: M. Shibata et al., Anti-inflammatory, antithrombotic, and neuroprotective effects of activated protein C in a murine model of focal ischemic stroke, CIRCULATION, 103(13), 2001, pp. 1799-1805
Authors:
Deguchi, H
Fernandez, JA
Pabinger, I
Heit, JA
Griffin, JH
Citation: H. Deguchi et al., Plasma glucosylceramide deficiency as potential risk factor for venous thrombosis and modulator of anticoagulant protein C pathway, BLOOD, 97(7), 2001, pp. 1907-1914
Authors:
Fernandez, JA
Kojima, K
Petaja, J
Hackeng, TM
Griffin, JH
Citation: Ja. Fernandez et al., Cardiolipin enhances protein C pathway anticoagulant activity, BL CELL M D, 26(2), 2000, pp. 115-123
Authors:
Pellequer, JL
Gale, AJ
Getzoff, ED
Griffin, JH
Citation: Jl. Pellequer et al., Three-dimensional model of coagulation factor Va bound to activated protein C, THROMB HAEM, 84(5), 2000, pp. 849-857
Authors:
Gale, AJ
Pellequer, JL
Getzoff, ED
Griffin, JH
Citation: Aj. Gale et al., Structural basis for hemophilia A caused by mutations in the C domains of blood coagulation factor VIII, THROMB HAEM, 83(1), 2000, pp. 78-85
Authors:
Griffin, JH
Deguchi, H
Fernandez, JA
Citation: Jh. Griffin et al., Causes of thrombophilia yet to be discovered: A personal view, HAEMOSTASIS, 30, 2000, pp. 26-33
Authors:
Hackeng, TM
Yegneswaran, S
Johnson, AE
Griffin, JH
Citation: Tm. Hackeng et al., Conformational changes in activated protein C caused by binding of the first epidermal growth factor-like module of protein S, BIOCHEM J, 349, 2000, pp. 757-764
Authors:
Mesters, RM
Helterbrand, J
Utterback, BG
Yan, SB
Chao, YB
Fernandez, JA
Griffin, JH
Hartman, DL
Citation: Rm. Mesters et al., Prognostic value of protein C concentrations in neutropenic patients at high risk of severe septic complications, CRIT CARE M, 28(7), 2000, pp. 2209-2216
Authors:
Deguchi, H
Fernandez, JA
Hackeng, TM
Banka, CL
Griffin, JH
Citation: H. Deguchi et al., Cardiolipin is a normal component of human plasma lipoproteins, P NAS US, 97(4), 2000, pp. 1743-1748
Authors:
Hackeng, TM
Fernandez, JA
Dawson, PE
Kent, SBH
Griffin, JH
Citation: Tm. Hackeng et al., Chemical synthesis and spontaneous folding of a multidomain protein: Anticoagulant microprotein S, P NAS US, 97(26), 2000, pp. 14074-14078
Authors:
Marx, PF
Hackeng, TM
Dawson, PE
Griffin, JH
Meijers, JCM
Bouma, BN
Citation: Pf. Marx et al., Inactivation of active thrombin-activable fibrinolysis inhibitor takes place by a process that involves conformational instability rather than proteolytic cleavage, J BIOL CHEM, 275(17), 2000, pp. 12410-12415
Authors:
Gale, AJ
Heeb, MJ
Griffin, JH
Citation: Aj. Gale et al., The autolysis loop of activated protein C interacts with factor Va and differentiates between the Arg506 and Arg306 cleavage sites, BLOOD, 96(2), 2000, pp. 585-593
Authors:
Lentz, SR
Fernandez, JA
Griffin, JH
Piegors, DJ
Erger, RA
Malinow, MR
Heistad, DD
Citation: Sr. Lentz et al., Impaired anticoagulant response to infusion of thrombin in atheroscleroticmonkeys associated with acquired defects in the protein C system, ART THROM V, 19(7), 1999, pp. 1744-1750
Authors:
Tabrizi, P
Wang, L
Seeds, N
McComb, JG
Yamada, S
Griffin, JH
Carmeliet, P
Weiss, MH
Zlokovic, BV
Citation: P. Tabrizi et al., Tissue plasminogen activator (tPA) deficiency exacerbates cerebrovascular fibrin deposition and brain injury in a murine stroke model - Studies in tPA-deficient mice and wild-type mice on a matched genetic background, ART THROM V, 19(11), 1999, pp. 2801-2806
Authors:
Bouma, BN
Mosnier, LO
Meijers, JCM
Griffin, JH
Citation: Bn. Bouma et al., Factor XI dependent and independent activation of Thrombin Activatable Fibrinolysis Inhibitor (TAFI) in plasma associated with clot formation, THROMB HAEM, 82(6), 1999, pp. 1703-1708
Authors:
Fernandez, JA
Petaja, J
Griffin, JH
Citation: Ja. Fernandez et al., Dermatan sulfate and LMW heparin enhance the anticoagulant action of activated protein C, THROMB HAEM, 82(5), 1999, pp. 1462-1468
Authors:
Xu, X
Bauer, KA
Griffin, JH
Citation: X. Xu et al., Two multiplex PCR-based DNA assays for the thrombosis risk factors prothrombin G20210A and coagulation factor V G1691A polymorphisms, THROMB RES, 93(6), 1999, pp. 265-269
Authors:
Macko, RF
Killewich, LA
Fernandez, JA
Cox, DK
Gruber, A
Griffin, JH
Citation: Rf. Macko et al., Brain-specific protein C activation during carotid artery occlusion in humans, STROKE, 30(3), 1999, pp. 542-545
Authors:
Hackeng, TM
Griffin, JH
Dawson, PE
Citation: Tm. Hackeng et al., Protein synthesis by native chemical ligation: Expanded scope by using straightforward methodology, P NAS US, 96(18), 1999, pp. 10068-10073
Authors:
Petaja, J
Pesonen, E
Fernandez, JA
Vento, AE
Ramo, OJ
Griffin, JH
Citation: J. Petaja et al., Cardiopulmonary bypass and activation of antithrombotic plasma protein C, J THOR SURG, 118(3), 1999, pp. 422-429